We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > PRS

News List

Adhering to Life's Simple 7 May Cut CHD Risk Despite Genetics drugs.com
February 08, 2022
Ideal adherence to the American Heart Association (AHA) Life's Simple 7 (LS7) guidelines is associated with a lower lifetime risk for coronary heart disease (CHD)...
Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis(IPF) shows promising result in early stage clinical test prnasia
May 28, 2021
Daewoong Pharmaceutical of South Korea has announced the promising clinical results of DWN12088, which is being developed as a first-in-class Prolyl-tRNA Synthetase(PRS) inhibitor for idiopathic pulmonary fibrosis (IPF) .
Polygenic Risk Score More Strongly Linked to Early-Onset CRC drugs
December 27, 2019
A polygenic risk score (PRS), developed from 95 colorectal cancer (CRC)-associated genetic risk variants, is more strongly associated with early- than late-onset cancer ...
Rare Variants Associated With Interval Breast Cancers drugs
December 04, 2018
Though common breast cancer variants indicate increased breast cancer risk, certain rare variants are associated with an increased risk for interval breast cancers and death, according to a study published in the Nov. 1 issue of Cancer Research.....